Chaired by Dr. Frederick Locke and Professor David Maloney, the workshop featured an esteemed faculty of over 70 international key opinion leaders. Together, they delivered a comprehensive and forward-looking agenda spanning the latest innovations across a wide range of therapeutic areas, including leukemias, lymphomas, multiple myeloma and solid tumors. Especially exciting this year was the inclusion of a wider autoimmune session in the programme, reflecting the growing momentum and potential of cell and immune therapies in this space. Sessions delved deep into the full spectrum of cellular and molecular technologies—T-cell engagers, TCRs, TILs, CARs, and other novel platforms—highlighting the evolving frontiers of immuno-oncology and cell-based therapies.
Healthcare professionals are invited to access the presentations from the workshop now available to view online https://www.vjhemonc.com/event/iwcar-t-2025/ and https://www.vjoncology.com/event/iwcar-t-2025/ and to watch the roundtable summaries of filmed onsite in our VJStudio set up.
The success of iwCAR-T 2024 would not have been possible without the generous support of our industry partners. Magdalen Scientific extends its sincere gratitude to Genentech, A2 Biotherapeutics, Bristol Myers Squibb (BMS), Johnson & Johnson, Kite Pharma, Autolus, Caribou Biosciences, Galapagos, Immatics, Legend Biotech, Miltenyi Biomedicine, Nkarta, Novartis, BioNTech, and Iovance Biotherapeutics for their sponsorship of the workshop.
At Magdalen Scientific, our mission is to foster meaningful dialogue and collaboration among the global healthcare professional community. Through events like iwCAR-T, we strive to create a dynamic environment for interaction, knowledge-sharing, and innovation—ultimately working toward our shared goal of improving patient outcomes. To learn more about our upcoming scientific workshops, please visit: https://magdalenscientific.com/workshops/
We look forward to continuing this important work and to welcoming the scientific community to iwCAR-T 2026 in Tampa, Florida and future editions of iwCAR-T.
